Clear all

Refine your search

Tags
Territory
Jurisdiction
Language

904 results found

Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 25 Apr 2022

World IP Day: A primer on Canadian intellectual property rights

The theme of World Intellectual Property Day this year is "IP and Youth: Innovating for a Better Future." In the spirit of contributing to…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 19 Apr 2022

2030 Emissions reduction plan and Canada’s journey to net zero

On March 29, 2022 the Government of Canada (Federal Government) delivered its 2030 Emissions Reduction Plan (the Plan);The Plan outlines current and…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 11 Apr 2022

Intellectual property highlights in the Federal Budget 2022

Amongst the other areas highlighted in the Foreword of the 2022 Federal Budget (Budget 2022), IP is specifically identified: “We will help Canadians…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 8 Apr 2022

Greening up Canadian patent rights by expediting green technologies

On March 29, 2022, the Federal Government delivered its 2030 Emissions Reduction Plan (the Plan). It is clear that the Plan strives to be…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 14 Jan 2022

New prior user rights provision in the Patent Act: first judicial consideration

In the context of a motion for summary judgment in Kobold Corporation et al v. NCS Multistage Inc., the Court provided the first judicial…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 5 Jan 2022

Trade secrets: The unsung hero of IP strategy

Trade secrets are a critical and valuable - yet often underused - asset for many businesses. They are a crucial part of any Intellectual Property (IP)…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 2 Dec 2021

Regulatory context for patented pharmaceuticals and biotechnology drugs in Canada

Canada has a number of regulations that intersect with the Patent Act and the drug approval process. These regulations inform the business decisions…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 1 Dec 2021

Scope of patent agent privilege provided by new section 16.1 considered by Court

In 2016, amendments were made to the Patent Act to provide privilege in respect of certain communications with patent agents. Section 16.1…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 6 Oct 2021

Protecting intellectual property: IP enforcement as part of a commercial strategy

Enforcing and protecting intellectual property (IP) is crucial for any business. In this latest article in our IP Asset series, we discuss enforcing…
Article
Ask Lexy

Borden Ladner Gervais LLP | Canada | 24 Jun 2021

Section 53.1 of the Patent Act - an update on the Canadian version of file wrapper estoppel

Nous sommes désolés. Le contenu de cette page n'est présentement disponible qu'en anglais. Prior to December 13, 2018, the law in Canada was that…
Previous page 1 2 3 ...